"
Team:Penn/SurfaceDisplayOverview
From 2012.igem.org
While engineering bacteria as a light-activated drug delivery system is novel and useful by itself, the targeting potential of our light-activated bacterial therapeutic would be greatly improved if the bacteria also could target specific cells. We sought to achieve this by displaying an engineered cancer cell binding protein on the surface of our E. coli.
